Sandra Patterson

Insightful analysis on the companies, events, and strategic shifts truly moving the world's markets.

SP
Editor
Sandra Patterson

About This Column

Sandra Patterson is a commentator and strategist who explores the intersection of corporate performance and market sentiment. Building on her background in analyzing high-stakes volatility, Sandra now delivers daily dispatches on the broad forces reshaping the 2026 investment landscape - from the impact of "AI fatigue" to the re-emergence of value stocks. With a reputation for providing a nuanced perspective on "the why behind the buy," she offers a unique lens on the catalysts that drive market momentum. Her writing is essential reading for anyone seeking to stay ahead of the curve in a complex and rapidly changing world.

Displaying items 161-180 of 824 in total

Bunkerhill Health's $55M Bet: Agentic AI as Healthcare's New Foundation

Read full article
Bunkerhill Health's $55M Bet: Agentic AI as Healthcare's New Foundation

Envestnet's Private Market Play: Due Diligence in the Age of Access

Read full article
Envestnet's Private Market Play: Due Diligence in the Age of Access

The Why Behind the Buy: VistaShares' New Supercycle® ETF Frontier

Read full article
The Why Behind the Buy: VistaShares' New Supercycle® ETF Frontier

The 60% Solution: How AI Unlocked Cash Flow for a Logistics Leader

Read full article
The 60% Solution: How AI Unlocked Cash Flow for a Logistics Leader

Waiākea's Paʻa Launch: Solidifying a Legacy in Sustainable Luxury

Read full article
Waiākea's Paʻa Launch: Solidifying a Legacy in Sustainable Luxury

Linkhome's $10.5M Bet: From Real Estate to AI's Decentralized Future

Read full article
BriefGlance

ExxonMobil's Carbon Bet: Big Oil Backs Startups for a Materials Revolution

Read full article
ExxonMobil's Carbon Bet: Big Oil Backs Startups for a Materials Revolution

Kura's Darlifarnib: A Catalyst for a New Era in Cancer Combination Therapy?

Read full article
Kura's Darlifarnib: A Catalyst for a New Era in Cancer Combination Therapy?

The 650-Mile March Challenging the Alzheimer's Market Narrative

Read full article
The 650-Mile March Challenging the Alzheimer's Market Narrative

Alarum's Crisis: A Tech Firm's Search for Answers Amid FBI Probe

Read full article
Alarum's Crisis: A Tech Firm's Search for Answers Amid FBI Probe

Janicki's $800M Montana Bet: A New Frontier for US Advanced Manufacturing

Read full article
Janicki's $800M Montana Bet: A New Frontier for US Advanced Manufacturing

FP Movement's Hamptons Play: Inside the Deal Redefining Luxury Retail

Read full article
FP Movement's Hamptons Play: Inside the Deal Redefining Luxury Retail

Sallie Mae's Q2 Report: A Litmus Test in a Remodeled Student Loan Market

Read full article
Sallie Mae's Q2 Report: A Litmus Test in a Remodeled Student Loan Market

A Digital Bridge to Dreams: How Prison Tech Fuels Opportunity and Debate

Read full article
A Digital Bridge to Dreams: How Prison Tech Fuels Opportunity and Debate

Beyond the Arena: Why the Wildcatters-Auris Deal Redefines Sponsorship

Read full article
Beyond the Arena: Why the Wildcatters-Auris Deal Redefines Sponsorship

OSL's MiCAR Win Signals a Flight to Quality in European Crypto

Read full article
OSL's MiCAR Win Signals a Flight to Quality in European Crypto

Monster Beverage's Stock Split: A Jolt of Confidence for Investors

Read full article
Monster Beverage's Stock Split: A Jolt of Confidence for Investors

Pronto Corp. vs. The Feds: A High-Stakes Bet on Fair Competition

Read full article
Pronto Corp. vs. The Feds: A High-Stakes Bet on Fair Competition

Cypress Creek's Strategic Investment in Tomorrow's Energy Workforce

Read full article
Cypress Creek's Strategic Investment in Tomorrow's Energy Workforce

Beyond the Lowest Bid: Procurement Is Now the Linchpin of Clean Energy

Read full article
Beyond the Lowest Bid: Procurement Is Now the Linchpin of Clean Energy
UCID: 40